Literature DB >> 23863052

Clinical practice: Herpes zoster.

Jeffrey I Cohen1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23863052      PMCID： PMC4789101          DOI： 10.1056/NEJMcp1302674

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  41 in total

1.  A single dose of gabapentin reduces acute pain and allodynia in patients with herpes zoster.

Authors:  James D Berry; Karin Lottrup Petersen
Journal:  Neurology       Date:  2005-08-09       Impact factor: 9.910

2.  Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50-59 years.

Authors:  Kenneth E Schmader; Myron J Levin; John W Gnann; Shelly A McNeil; Timo Vesikari; Robert F Betts; Susan Keay; Jon E Stek; Nickoya D Bundick; Shu-Chih Su; Yanli Zhao; Xiaoming Li; Ivan S F Chan; Paula W Annunziato; Janie Parrino
Journal:  Clin Infect Dis       Date:  2012-01-30       Impact factor: 9.079

3.  Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment study.

Authors:  B S Galer; M C Rowbotham; J Perander; E Friedman
Journal:  Pain       Date:  1999-04       Impact factor: 6.961

4.  A multicenter, randomized, double-blind, controlled study of NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia.

Authors:  Gordon A Irving; Miroslav M Backonja; Edwin Dunteman; E Richard Blonsky; Geertrui F Vanhove; Shiao-Ping Lu; Jeffrey Tobias
Journal:  Pain Med       Date:  2010-11-18       Impact factor: 3.750

5.  Vaccination against Herpes Zoster and Postherpetic Neuralgia.

Authors:  Michael N Oxman; Myron J Levin
Journal:  J Infect Dis       Date:  2008-03-01       Impact factor: 5.226

6.  Safety of zoster vaccine in elderly adults following documented herpes zoster.

Authors:  Vicki A Morrison; Michael N Oxman; Myron J Levin; Kenneth E Schmader; John C Guatelli; Robert F Betts; Larry D Gelb; Constance T Pachucki; Susan K Keay; Barbara Menzies; Marie R Griffin; Carol A Kauffman; Adriana R Marques; John F Toney; Michael S Simberkoff; Richard Serrao; Robert D Arbeit; John W Gnann; Richard N Greenberg; Mark Holodniy; Wendy A Keitel; Shingshing S Yeh; Larry E Davis; George E Crawford; Kathy M Neuzil; Gary R Johnson; Jane H Zhang; Rith Harbecke; Ivan S F Chan; Paul M Keller; Heather M Williams; Kathy D Boardman; Jeffrey L Silber; Paula W Annunziato
Journal:  J Infect Dis       Date:  2013-04-30       Impact factor: 5.226

7.  Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia.

Authors:  C P Watson; N Babul
Journal:  Neurology       Date:  1998-06       Impact factor: 9.910

8.  Transmission of a newly characterized strain of varicella-zoster virus from a patient with herpes zoster in a long-term-care facility, West Virginia, 2004.

Authors:  Adriana S Lopez; Andrea Burnett-Hartman; Ram Nambiar; Linda Ritz; Patricia Owens; Vladimir N Loparev; Dalya Guris; D Scott Schmid
Journal:  J Infect Dis       Date:  2008-03-01       Impact factor: 5.226

9.  Famciclovir for the treatment of acute herpes zoster: effects on acute disease and postherpetic neuralgia. A randomized, double-blind, placebo-controlled trial. Collaborative Famciclovir Herpes Zoster Study Group.

Authors:  S Tyring; R A Barbarash; J E Nahlik; A Cunningham; J Marley; M Heng; T Jones; T Rea; R Boon; R Saltzman
Journal:  Ann Intern Med       Date:  1995-07-15       Impact factor: 25.391

10.  A randomized, placebo-controlled trial of oxycodone and of gabapentin for acute pain in herpes zoster.

Authors:  Robert H Dworkin; Richard L Barbano; Stephen K Tyring; Robert F Betts; Michael P McDermott; Janet Pennella-Vaughan; Gary J Bennett; Erhan Berber; John W Gnann; Carrie Irvine; Cornelia Kamp; Karl Kieburtz; Mitchell B Max; Kenneth E Schmader
Journal:  Pain       Date:  2009-02-04       Impact factor: 6.961
View more
  161 in total

Review 1.  Herpes zoster epidemiology, management, and disease and economic burden in Europe: a multidisciplinary perspective.

Authors:  Robert W Johnson; Marie-José Alvarez-Pasquin; Marc Bijl; Elisabetta Franco; Jacques Gaillat; João G Clara; Marc Labetoulle; Jean-Pierre Michel; Luigi Naldi; Luis S Sanmarti; Thomas Weinke
Journal:  Ther Adv Vaccines       Date:  2015-07

2.  Impact of Antiretroviral Therapy on the Risk of Herpes Zoster among Human Immunodeficiency Virus-Infected Individuals in Tanzania.

Authors:  Kosuke Kawai; Claudia A Hawkins; Ellen Hertzmark; Joel M Francis; David Sando; Aisa N Muya; Nzovu Ulenga; Wafaie W Fawzi
Journal:  Am J Trop Med Hyg       Date:  2018-01-04       Impact factor: 2.345

3.  Increasing Incidence of Herpes Zoster Over a 60-year Period From a Population-based Study.

Authors:  Kosuke Kawai; Barbara P Yawn; Peter Wollan; Rafael Harpaz
Journal:  Clin Infect Dis       Date:  2016-05-08       Impact factor: 9.079

4.  Peripheral nervous system manifestations of infectious diseases.

Authors:  Kate T Brizzi; Jennifer L Lyons
Journal:  Neurohospitalist       Date:  2014-10

5.  A retrospective survey on herpes zoster disease burden and characteristics in Beijing, China.

Authors:  Li Lu; Luodan Suo; Juan Li; Xinghuo Pang
Journal:  Hum Vaccin Immunother       Date:  2018-07-30       Impact factor: 3.452

Review 6.  [Use of intracutaneous or subcutaneous botulinum toxin for postherpetic neuralgia].

Authors:  L Halb; B J Amann; H Bornemann-Cimenti
Journal:  Nervenarzt       Date:  2017-04       Impact factor: 1.214

Review 7.  Prevention of Herpes Zoster and its complications: From clinical evidence to real life experience.

Authors:  Giovanni Gabutti; Paolo Bonanni; Michele Conversano; Guido Fanelli; Elisabetta Franco; Donato Greco; Giancarlo Icardi; Marzia Lazzari; Alessandro Rossi; Silvestro Scotti; Antonio Volpi
Journal:  Hum Vaccin Immunother       Date:  2016-12-07       Impact factor: 3.452

8. 

Authors:  María José Monedero Mira; Manuel Batalla Sales; Concepción García Domingo; María José Monedero Mira; Belén Persiva Saura; Gloria Rabanaque Mallen; Lledó Tárrega Porcar
Journal:  FMC       Date:  2016-04-26

9.  Herpes zoster encephalopathy or acyclovir neurotoxicity: a management dilemma.

Authors:  Daniel Sacchetti; Aydah Alawadhi; Mustafa Albakour; Alwyn Rapose
Journal:  BMJ Case Rep       Date:  2014-04-28

10.  Varicella-zoster virus (VZV) infection as a possible cause of Ogilvie's syndrome in an immunocompromised host.

Authors:  Miguel F Carrascosa; José R Salcines-Caviedes; Javier Gómez Román; Marta Cano-Hoz; Marta Fernández-Ayala; Elena Casuso-Sáenz; Ismael Abascal-Carrera; Ana Campo-Ruiz; Marta Cobo Martín; Ainhoa Díaz-Pérez; Pablo González-Gutiérrez; José M Aguado
Journal:  J Clin Microbiol       Date:  2014-05-07       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.